Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

New hormone drug to cheer flagging libido

Friday 23 February 1996 00:02 GMT
Comments

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

A new hormone replacement therapy being developed by a British company could be the answer to flagging libido in middle-aged men, it was claimed yesterday, writes Magnus Grimond.

Hormone replacement has become an established treatment for post-menopausal women to combat osteoporosis, or "brittle bone disease". But recent research has focused on the use of similar treatments for men suffering from the so-called "male menopause" - decreased libido, impotence, tiredness and depression.

Yesterday, the development of an oral form of the male hormone testosterone took a major step forward when Cortecs International, one of a growing band of UK companies set up to exploit medical breakthroughs, signed a collaboration agreement with a Danish group to finance development of the drug.

But sufferers may have to wait a while yet for relief. Cortecs does not expect to receive regulatory approval until the year 2000, with a further 18 months to two years before it hits the market.

Join our commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in